X4 PHARMACEUTICALS, INC Loans Payable, Noncurrent
X4 PHARMACEUTICALS, INC (XFOR) had Loans Payable, Noncurrent of $7.89 million as of 2018-12-31, per its 10-K filed 2019-03-11.
Discontinued › Balance Sheet › Liabilities › Liabilities, Noncurrent › Long-Term Debt, Excluding Current Maturities
us-gaap:LongTermLoansPayable · last filed 2019-03-11
- 2018-12-31: Loans Payable, Noncurrent $7.89M.
- 2018-09-30: Loans Payable, Noncurrent $7.83M.
- 2018-06-30: Loans Payable, Noncurrent $7.71M.
- 2018-03-31: Loans Payable, Noncurrent $9.70M.
| Period end | Loans Payable, Noncurrent |
|---|---|
| 2018-12-31 | $7.89M 10-K · filed 2019-03-11 |
| 2018-09-30 | $7.83M 10-Q · filed 2018-11-09 |
| 2018-06-30 | $7.71M 10-Q · filed 2018-08-13 |
| 2018-03-31 | $9.70M 10-Q · filed 2018-05-10 |
| 2017-12-31 | $9.92M 10-K · filed 2019-03-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Inhibikase Therapeutics, Inc. (IKT) | United States | $0.296B | -4.44 |
| SAB Biotherapeutics, Inc. (SABS) | United States | $0.306B | -25.49 |
| Century Therapeutics, Inc. (IPSC) | United States | $0.306B | -4.02 |
| Liminatus Pharma, Inc. (LIMN) | United States | $0.282B | |
| FATE THERAPEUTICS INC (FATE) | United States | $0.280B | -2.51 |
| Lexeo Therapeutics, Inc. (LXEO) | United States | $0.278B | -4.19 |
| PALISADE BIO, INC. (PALI) | United States | $0.275B | -11.41 |
| Invivyd, Inc. (IVVD) | United States | $0.270B | -2.42 |
| SUTRO BIOPHARMA, INC. (STRO) | United States | $0.260B | -3.05 |
| Ocugen, Inc. (OCGN) | United States | $0.343B | -6.34 |